Cargando…
Direct comparison shows that mRNA-based diagnostics incorporate information which cannot be learned directly from genomic mutations
BACKGROUND: Compared to the many uses of DNA-level testing in clinical oncology, development of RNA-based diagnostics has been more limited. An exception to this trend is the growing use of mRNA-based methods in early-stage breast cancer. Although DNA and mRNA are used together in breast cancer rese...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236449/ https://www.ncbi.nlm.nih.gov/pubmed/32429832 http://dx.doi.org/10.1186/s12859-020-3512-z |